Skip to content

Electroacupuncture of different treatment frequency on pregnancy outcome of FET in infertile patients: a pilot randomized controlled trial

Clinical efficacy of electroacupuncture on pregnancy outcome of FET in infertile patients: a pilot randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077362
Enrollment
Unknown
Registered
2023-11-06
Start date
2023-11-09
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

group H:Electroacupuncture of high treatment frequency and FET therapy will be administered
group H:Electroacupuncture of low treatment frequency and FET therapy will be administered
group N:FET therapy only

Sponsors

Sichuan Jinxin Xi'nan Women's and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 37 Years

Inclusion criteria

Inclusion criteria: 1) Infertile patients undergoing FET and had no more than 2 previous transplantation cycles; 2) 21= age < 38 years old; 3) At least one good-quality blastocyst (fertilized by IVF); 4) Patients with a hormone replacement cycle regimen for endometrial preparation; 5) Hysteroscopy was completed and showed no abnormalities; 6) Informed consent was obtained voluntarily.

Exclusion criteria

Exclusion criteria: 1) The patients with autoimmune diseases or a prothrombotic state; 2) The patient has uterine malformations (unicornis, bicornis, bicornis, or untreated uterine diaphragm) or other untreated conditions that can damage the endometrial cavity, such as adenomyopathy, submucosal fibroids, uterine adhesions, or a scarred uterus; 3) Combined with uncorrected hyperprolactinemia, hyperandrogenemia, thyroid dysfunction, chronic adrenocortical hypofunction and other metabolic endocrine diseases; 4) Patients with chromosomal abnormalities; 5)Those who have bleeding tendency and are prone to infection, or have severe allergies, or have ulcers and scars on the skin are prohibited from acupuncture; 6)Patients who received acupuncture treatment in the last three months; 7)Patients who are participating in other clinical trials

Design outcomes

Primary

MeasureTime frame
clinical pregnancy;

Secondary

MeasureTime frame
Salle score;biochemical pregnancy;embryo implantation;live birth;patient recruitment;adherence to treatment;

Countries

China

Contacts

Public ContactJie Yang

1.Chengdu University of Traditional Chinese Medicine 2.Sichuan Jinxin Xinan Women and Children Hospital (formerly "Chengdu Xi’nan Gynecological Hospital")

jenny_yang_jie@126.com+86 138 8229 6714

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026